Peptide firms unveil new research services for smaller labs

Several companies announced services aimed at researchers amid growing interest in peptide products. Hangzhou XinHai Pharmaceutical Technology (Thinheal) promotes end-to-end custom peptide development, from synthesis and analytical testing to scale-up and regulatory documentation, addressing technical and infrastructure challenges for smaller research teams. Volta Peptides says its new Certificates of Analysis include purity, endotoxin and heavy-metal testing, and it offers North American warehouse shipping; it states its products are for in-vitro research only, not human or animal use. Certified-PEP launched a dedicated KLOW peptide blend information site, citing rising online searches and demand for clearer information. These announcements reflect commercial efforts around peptide research and supply, but the company-reported performance, quality and market claims were not independently verified in the articles.